Tokio Marine Asset Management Co. Ltd. Makes New $411,000 Investment in Revvity, Inc. (NYSE:RVTY)

Tokio Marine Asset Management Co. Ltd. bought a new position in Revvity, Inc. (NYSE:RVTY) in the fourth quarter, HoldingsChannel.com reports. The fund bought 3,764 shares of the company’s stock, valued at approximately $411,000.

A number of other institutional investors also recently modified their holdings of RVTY. Parkside Financial Bank & Trust bought a new stake in shares of Revvity during the fourth quarter worth approximately $25,000. Gladius Capital Management LP boosted its holdings in shares of Revvity by 84.1% in the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock valued at $26,000 after buying an additional 106 shares during the period. CENTRAL TRUST Co acquired a new position in shares of Revvity in the fourth quarter valued at approximately $27,000. ORG Partners LLC bought a new stake in shares of Revvity in the fourth quarter worth $32,000. Finally, JTC Employer Solutions Trustee Ltd bought a new stake in shares of Revvity in the fourth quarter worth $33,000. 86.65% of the stock is owned by institutional investors.

Revvity Price Performance

Shares of RVTY opened at $101.51 on Monday. The firm has a market capitalization of $12.54 billion, a PE ratio of 18.46, a PEG ratio of 2.64 and a beta of 1.09. The company’s 50-day moving average is $104.66 and its 200-day moving average is $101.34. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $132.54. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.07 and a quick ratio of 1.77.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.10. The company had revenue of $695.90 million for the quarter. Revvity had a net margin of 25.20% and a return on equity of 7.41%. Equities analysts forecast that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.28%. The ex-dividend date is Friday, July 19th. Revvity’s payout ratio is presently 5.09%.

Insider Activity

In related news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction dated Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the transaction, the insider now directly owns 92,801 shares in the company, valued at $9,677,288.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. UBS Group lowered shares of Revvity from a “buy” rating to a “neutral” rating and boosted their price objective for the stock from $105.00 to $125.00 in a research report on Tuesday, January 16th. Barclays boosted their price objective on shares of Revvity from $92.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. Evercore ISI raised shares of Revvity from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $88.00 to $125.00 in a research report on Thursday, January 4th. Stifel Nicolaus upped their price target on shares of Revvity from $95.00 to $110.00 and gave the stock a “hold” rating in a research report on Friday, February 2nd. Finally, KeyCorp upped their price target on shares of Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $118.91.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.